Biologics Market Size, Share, Growth & Industry Analysis, By Source (Microbial, Mammalian), By Product (Monoclonal Antibodies (mAbs), Vaccines, Recombinant Proteins, Gene Therapies, Cell Therapies, Others), By Application (Oncology, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, and Other Applications), and Regional Analysis, 2024-2031

TABLE OF CONTENT

1 INTRODUCTION OF THE GLOBAL BIOLOGICS MARKET 
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL BIOLOGICS MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 GLOBAL BIOLOGICS MARKET, BY SOURCE
5.1 Overview
5.2 Microbial
5.3 Mammalian

6 GLOBAL BIOLOGICS MARKET, BY PRODUCT
6.1 Overview
6.2 Monoclonal Antibodies (mAbs)
6.3 Vaccines
6.4 Recombinant Proteins
6.5 Gene Therapies
6.6 Cell Therapies
6.7 Others

7 GLOBAL BIOLOGICS MARKET, BY APPLICATION
7.1 Overview
7.2 Oncology
7.3 Infectious Diseases
7.4 Cardiovascular Diseases
7.5 Autoimmune Diseases
7.6 Other Applications

8 GLOBAL BIOLOGICS MARKET, BY GEOGRAPHY
8.1 Overview

9 NORTH AMERICA 
9.1 U.S.
9.2 Canada
9.3 Mexico

10 EUROPE 
10.1 France
10.2 UK
10.3 Spain
10.4 Germany
10.5 Italy
10.6 Russia
10.7 Rest of Europe

11 ASIA-PACIFIC 
11.1 China
11.2 Japan
11.3 India
11.4 Australia
11.5 ASEAN
11.6 South Korea
11.7 Rest of Asia-Pacific

12 MIDDLE EAST & AFRICA 
12.1 Turkey
12.2 UAE
12.3 Saudi Arabia
12.4 South Africa
12.5 Rest of Middle East & Africa

13 SOUTH AMERICA 
13.1 Brazil
13.2 Argentina
13.3 Rest of South America

14  GLOBAL BIOLOGICS MARKET COMPETITIVE LANDSCAPE
14.1 Overview
14.2 Key Developments
14.3 Key Strategic Developments
14.4 Company Market Ranking
14.5 Regional Footprint
14.6 Industry Footprint

15 COMPANY PROFILES
15.1 Eli Lilly and Company
15.2 Johnson & Johnson Services, Inc.
15.3 F. Hoffmann-La Roche Ltd
15.4 Pfizer Inc.
15.5 Gilead Sciences, Inc.
15.6 Bristol-Myers Squibb Company
15.7 Novo Nordisk A/S
15.8 Merck KGaA
15.9 AbbVie Inc.
15.10 Novartis AG
15.11 GSK plc.
15.12 AstraZeneca
15.13 Regeneron Pharmaceuticals Inc.
15.14 Sanofi
15.15 Takeda Pharmaceutical Company Limited
15.16 Others

LIST OF TABLES

TABLE 1 Global Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 2 Global Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 3 Global Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 4 Global Biologics Market Revenue, By Geography, 2021 – 2031 (USD Billion)
TABLE 5 North America Biologics Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 6 North America Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 7 North America Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 8 North America Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 9 US Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 10 US Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 11 US Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 12 Canada Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 13 Canada Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 14 Canada Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 15 Mexico Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 16 Mexico Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 17 Mexico Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 18 Europe Biologics Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 19 Europe Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 20 Europe Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 21 Europe Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 22 Germany Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 23 Germany Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 24 Germany Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 25 France Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 26 France Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 27 France Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 28 U.K. Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 29 U.K. Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 30 U.K. Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 31 Spain Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 32 Spain Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 33 Spain Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 34 Italy Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 35 Italy Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 36 Italy Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 37 Russia Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 38 Russia Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 39 Russia Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 40 Rest of Europe Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 41 Rest of Europe Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 42 Rest of Europe Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 43 Asia-Pacific Biologics Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 44 Asia-Pacific Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 45 Asia-Pacific Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 46 Asia-Pacific Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 47 China Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 48 China Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 49 China Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 50 Japan Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 51 Japan Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 52 Japan Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 53 India Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 54 India Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 55 India Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 56 South Korea Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 57 South Korea Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 58 South Korea Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 59 Rest of Asia-Pacific Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 60 Rest of Asia-Pacific Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 61 Rest of Asia-Pacific Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 62 Middle East and Africa Biologics Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 63 Middle East and Africa Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 64 Middle East and Africa Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 65 Middle East and Africa Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 66 GCC Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 67 GCC Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 68 GCC Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 69 North Africa Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 70 North Africa Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 71 North Africa Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 72 South Africa Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 73 South Africa Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 74 South Africa Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 75 Rest of Middle East & Africa Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 76 Rest of Middle East & Africa Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 77 Rest of Middle East & Africa Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 78 Latin America Biologics Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 79 Latin America Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 80 Latin America Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 81 Latin America Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 82 Brazil Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 83 Brazil Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 84 Brazil Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 85 Argentina Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 86 Argentina Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 87 Argentina Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 88 Rest of Latin America Biologics Market Revenue, By Source, 2021 – 2031 (USD Billion)
TABLE 89 Rest of Latin America Biologics Market Revenue, By Product, 2021 – 2031 (USD Billion)
TABLE 90 Rest of Latin America Biologics Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 91 Company Market Ranking
TABLE 92 Regional Footprint
TABLE 93 Product Benchmarking
TABLE 94 Recent Developments
TABLE 95 Winning Imperatives

LIST OF FIGURES

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Biologics Market 2021-2031 (USD Billion)
FIG. 4 Global Biologics Market Geographical Analysis (CAGR %)
FIG. 5 Global Biologics Absolute Market Opportunity (USD Billion)
FIG. 6 Global Biologics Market Attractiveness (USD Billion)
FIG. 7 Global Biologics Market, By Source, 2021-2031 (USD Billion)
FIG. 8 Global Biologics Market, By Product, 2021-2031 (USD Billion)
FIG. 9 Global Biologics Market, By Application, 2021-2031 (USD Billion)
FIG. 10 Research Methodology
FIG. 11 Research Process
FIG. 12 Bottom-Up Approach
FIG. 13 Top-Bottom Approach
FIG. 14 Market Dynamics Overview
FIG. 15 Porter's Five Forces Analysis
FIG. 16 Value Chain Analysis
FIG. 17 Macroeconomic Analysis
FIG. 18 Global Biologics Market Revenue Share, By Source, 2021 and 2031 (%)
FIG. 19 Global Biologics Market Revenue Share, By Product, 2021 and 2031 (%)
FIG. 20 Global Biologics Market Revenue Share, By Application, 2021 and 2031 (%)
FIG. 21 Global Biologics Market Revenue Share, By Geographic Regions, 2021 and 2031 (%)
FIG. 22 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 23 North America Biologics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 24 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 25 Europe Biologics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 26 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 27 Asia-Pacific Biologics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 28 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 29 Middle East & Africa Biologics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 30 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 31 Latin America Biologics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 32 Key Strategic Development
FIG. 33 Key Facts
FIG. 34 Financial Overview
FIG. 35 SWOT Analysis